Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, has joined with 40 other centers in the U.S. and Europe as a site in one of the first clinical trials ...
Recent advancements include targeted agents, immunotherapy, and fertility-sparing surgeries for patients with advanced ...
CHICAGO — For patients with advanced heart failure, an injection of autologous mononuclear cells into damaged myocardia missed the primary endpoint in the sham-controlled, randomized, blinded CardiAMP ...
Recent advances in developing cellular therapies, a broad group of strategies that use cells to treat disease, have shown efficacy in some types of blood cancer. Chimeric antigen receptor T (CAR T) ...
The cutting edge of treating solid tumors with cell therapies got notably sharper this year. As the director of Solid Tumor Cell Therapy and leader of Stanford Medicine’s Melanoma and Cutaneous ...
Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain investigational. Overall, the ATALANTA-1 data reinforce that optimized autologous ...
A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients ...
NEW YORK STATE, USA — In an effort to accelerate cell and gene therapy, five New York research centers are teaming up to create the Empire State Cellular Therapy Consortium. The consortium includes ...
CORAL GABLES, Fla., April 30, 2025 /PRNewswire/ -- Premier NAD+ IV Therapy and Wellness, an advanced wellness center in Coral Gables, FL, specializes in cutting-edge NAD+ infusion therapies to enhance ...
“There are leaps that occur in cancer treatment and with cellular therapy,” says Damian Green, M.D., chief of the Division of Transplantation and Cellular Therapy at Sylvester “We are at one of those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results